Approved Study Database

Ref. No. Scientific Title Principal investigator
2024.431 Hybrid cohort and case-control study on male urinary HPV in selected groups Dr. TEOH Jeremy Yuen Chun
2024.445 The effect of medication reconciliation and discharge counseling by ward pharmacists on 30-day readmission rate: A Retrospective Study at Prince of Wales Hospital Ms. IP Wing Tung
2024.439 A Validation Study of the Hong Kong Version of the Personal Impact of Epilepsy Scale (HK-PIES) for People with Epilepsy in Hong Kong Dr. CHAN Cheuk Him Charlie
2024.429 A Phase 2b/3, Multi-part, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Atacicept in Subjects with IgA Nephropathy (IgAN) Prof. SZETO Cheuk Chun
2024.433 Evaluation of innovative school-based interventions on health outcomes among primary school students during post COVID-19 pandemic Prof. LAU Ying
劉櫻
2024.430 Cardio- and Cerebrovascular Disease Biobank for Research Dr. IP Bonaventure Yiu Ming
2024.423 Utilisation of Big Data Analytics to Enhance Survival for Patients Living with Cancers Prof. HUANG Junjie
2024.424 Risk stratification of acid suppressant-related major adverse events in Asians: a retrospective cohort study Prof. HUANG Junjie
2024.425 An Open-Label, Multicenter, Phase 1 Study of AN4005 in Patients with Advanced Tumors Dr. LOONG Herbert Ho Fung
2024.459 Enhancing Cardiometabolic Health in Postnatal Women at High-Risk for Preeclampsia Through Exercise Intervention Prof. POON Chiu Yee Liona
2024.550 Incidence and Predictors for Long-Term Nephrotoxicity in Childhood Cancer Survivors Dr. LEE Vincent
2024.419 Dysarthric Speech Pattern Detection, Analysis and Reconstruction for Rehabilitation Training Prof. MENG Mei-Ling, Helen
蒙美玲
2024.428 The disease burden of RSV infection in Hong Kong Prof. HUI David Shu Cheong
2024.418 An evaluation of the effectiveness and cost-effectiveness of the Chronic Disease Co-Care (CDCC) Pilot Scheme: a commissioned study Dr Leung Shuk Yun
2024.477 Clinical Characteristics of Patient with Tumour Induced Osteomalacia in Hong Kong Dr. OZAKI Risa
2024.421 Validation of a breath-based test in predicting response of carvedilol in patients with compensated advanced chronic liver disease Dr. LAI Jimmy Che To
Grace LH Wong
2024.427 Risk factors associated with Multi-drug resistant organisms (MDRO) carrier status in three Residential Care Homes for the Elderly (RCHE) in Tai Po district Dr LEUNG Stephanie Siu Tung
2024.426 The association of refractive error and deviation control of patients with intermittent exotropia in Hong Kong Mr. YAU Tsz Him
2024.412 Comparison of Acute Kidney Injury Risk Prediction Scores after Aortic and Cardiac Surgery Dr. LEE Christopher P.T.
2024.417 Assessing Cancer Risk and Comorbidities in Diabetic vs. Non-Diabetic Patients in Hong Kong: a retrospective cohort study Prof. HUANG Junjie
2024.416 Independent double-checking of medication in emergency departments of hospitals: A sequential mixed-methods design Professor Lau Ying
2024.411 Effect of feedback devices on chest compression quality in Hong Kong nurses: A cross-over manikin study Mr. LEE Wai Yat
李瑋日
2024.398 Adjunctive Fludrocortisone in Septic Shock: a multicenter, double-blind, randomized, placebo-controlled pilot trial (AFLUDROS-1) Dr LING Lowell
2024.396 Integrative machine learning analysis of gut microbiome for predicting conversion from mild cognitive impairment to dementia Dr. LEE Allen Ting Chun
2024.400 Emergency Stroke Unit for Acute Cerebrovascular Events: A Prospective, Single-arm Trial with a Historical Control Group Prof. LEUNG Thomas Wai Hong
2024.395 Non-curative ESDs: Assessing the Rates and Risk Factors for Residual Neoplasia Dr. YIP Hon Chi
葉瀚智
2024.407 Measuring the neural markers of hearing and spatial hearing in normal hearing and hearing impaired using functional near-infrared spectroscopy and electroencephalography Dr. SCHNUPP Jan
2024.389 Community burden of Mycoplasma genitalium infection and its implications for test-and-treat strategies Prof. WONG Ngai Sze
2024.409 A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy Prof. YEO Winnie
2024.410 Effects of High-Intensity Interval Training on Cardiometabolic, Cognitive and Mental Health in Hong Kong Adolescents with Intellectual Disabilities: A Cluster-Randomized Controlled Trial Prof. POON Eric Tsz Chun
Eric Tsz-chun Poon
2024.397 Beamion LUNG-2: A Phase III, open-label, randomized, active-controlled, multi-centre trial evaluating orally administered zongertinib (BI 1810631) compared with standard of care as first-line treatment in patients with unresectable, locally advanced or metastatic non-squamous non-small cell lung cancer harbouring HER2 tyrosine kinase domain mutations Dr. LOONG Ho Fung Herbert
2024.401 Evaluating a novel, allosteric glucokinase activator in monogenic diabetes secondary to inactivating glucokinase mutations: a randomised, cross-over trial Dr Chow Elaine
2024.413 Analysis of Time to diagnosis & Outcomes of Primary Hyperparathyroidism in adults in a local hospital Dr. LAM Long Yi
2024.392 Integration of team-based learning and simulation-based learning in clinical education of infant dysphagia assessment and management of Speech-Language Pathology students: A cross-sectional observational study Ms. KWAN Ching Yin
關靜然
2024.399 Combined Leadless Pacemaker and Left Atrial Appendage Occlusion Registry Prof Tam Tsz Kin
譚子健
2024.394 Mycophenolate mofetil in Chinese patients with immune thrombocytopenia Dr. WONG Raymond
2024.393 Integrating Novel Artificial Intelligence-Based Privacy-Preserving Technology with Multi-centre Heterogeneous Data for Assessing Eye and Systemic Diseases Dr. HO Mary
2024.390 The disease epidemiology and treatment of haemophilia A and B patients in Hong Kong Dr. WONG Raymond Siu Ming
王紹明
2024.388 Prevalence of Small Vessel Disease in Patients with Cardiovascular Risk Factors - A hospital-based study Dr. IP Bonaventure Yiu Ming
2024.408 Preoperative continuous PENG block for geriatric hip fracture patients: a pilot feasibility study Dr Teng Irving
2024.380 Genome Study of Myopia Endophenotypes, Development, Progression and Intervention in Chinese Children Prof. CHEN Lijia
Yan Yu Julia CHAN
2024.403 Functional characterization of a novel 19q13 KRAB-zinc-finger repressor in regulating cancer stemness and metastasis of esophageal cancer Professor Tao Qian
2024.381 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants with Immunoglobulin A Nephropathy (IgAN) Prof. SZETO Cheuk Chun
司徒卓俊
2024.379 Phase 2 Study of Futibatinib 20 mg and 16 mg in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements Prof. CHAN Stephen Lam
2024.404 Outcome prediction of breast cancer patients with neoadjuvant therapy Prof. TSE Gary Man Kit
謝文杰
2024.415 Independent double-checking of medication in emergency departments of hospitals: A sequential mixed-methods design Ms. CHUNG Yuen Man Josephine
鐘婉雯
2024.414 Independent double-checking of medication in emergency departments of hospitals: A sequential mixed-methods design Ms. SHIU Irene Yuk Chun
蕭玉珍
2024.405 FOXC1 regulatory network in trastuzumab resistance of HER2+ breast cancer and potential clinical values Dr. TSE Gary Man-Kit
謝文杰
2024.386 A Multimodal AI-driven Platform for Precision Risk Assessment of Oral Potentially Malignant Disorders to Improve Prevention and Early Detection of Oral Cancer Prof. CHAN Jason Ying Kuen
2024.402 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Povetacicept in Adults with Immunoglobulin A Nephropathy (RAINIER) Prof. SZETO Cheuk Chun
司徒卓俊

Page 9 of 262.